SNRNP70: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

Target Name: SNRNP70

NCBI ID: G6625

SNRNP70

SNRNP70: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

SNRNP70 (U170K) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study.

SNRNP70 is a member of the SNRNP family, which is known for its role in regulating gene expression and other cellular processes. The SNRNP family consists of various RNA molecules that have distinct properties, such as the ability to interact with specific DNA sequences and the presence of conservative domains that are important for their function.

One of the defining features of SNRNP70 is its unique structure. It is a small RNA molecule that is composed of only 19 amino acids. Despite its small size, SNRNP70 is able to interact with DNA sequences that are up to several kilobases long. This ability to interact with long DNA sequences is unique and has important implications for its function in gene regulation.

SNRNP70 has been shown to play a role in the regulation of gene expression in various organisms, including humans. For example, studies have shown that SNRNP70 can interact with the gene encoding the protein PIK3CA, which is known to contribute to the development of various cancers . Additionally, SNRNP70 has been shown to interact with the gene encoding the protein NOTCH1, which is involved in the development of neurodegenerative diseases.

SNRNP70's unique structure and its ability to interact with DNA sequences have also made it an attractive target for researchers studying the insights of gene regulation. By studying the interaction between SNRNP70 and DNA sequences, researchers can gain into how genetic information is transcribed into RNA and how this process is regulated.

In addition to its potential as a drug target, SNRNP70 has also been shown to have potential as a biomarker. Its unique structure and function make it an attractive candidate for use as a diagnostic or predictive marker for various diseases. For example, studies have shown that SNRNP70 can be used as a biomarker for cancer, with promising results in clinical trials.

The potential of SNRNP70 as a drug target or biomarker is still being explored, but its unique structure and function have already led to a number of promising findings. Further research is needed to fully understand its role in gene regulation and its potential as a therapeutic or diagnostic agent.

Protein Name: Small Nuclear Ribonucleoprotein U1 Subunit 70

Functions: Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome (PubMed:19325628, PubMed:25555158). SNRNP70 binds to the loop I region of U1-snRNA (PubMed:2467746, PubMed:19325628, PubMed:25555158)

The "SNRNP70 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNRNP70 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets